Insider filing · STOK
Edward M. MD Kaye
Director
profile →
Stoke Therapeutics, Inc.
STOK · Healthcare · 33 filings in 24 months
ticker →
Edward M. MD Kaye sold $1.2M of Stoke Therapeutics (STOK)
Executed Sep 2 2025, disclosed Sep 3 2025, 1 day later.
Value, as filed
$1.2M
60,856 sh across 2 lots
Executed
Sep 2 2025
the trade date, as filed
Disclosed
Sep 3 2025
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
EKEdward M. MD Kaye (Director) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in Cytokinetics, Incorporated (CYTK). The largest single filing was $1.9M of CYTK (28,064 sh × $66.72, as filed), executed Dec 1 2025.
The name
STOKHealthcare · Stoke Therapeutics, Inc. engages in the development of treatments for severe genetic diseases by upregulating protein expression
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Edward M. MD Kaye in STOK
STOKSALE
Stoke Therapeutics, Inc.
$382K11,930 sh × $32.01
Exec Aug 18
Filed Aug 18 · 8:28 PM ET STOKSALE Stoke Therapeutics, Inc. $389K
12,099 sh across 2 lots
Exec Dec 8 2025
Filed Dec 10 2025 · 5:30 PM ET STOKSALE Stoke Therapeutics, Inc. $360K
11,589 sh across 2 lots
Exec Dec 4 2025
Filed Dec 5 2025 · 5:30 PM ET STOKSALE Stoke Therapeutics, Inc. $750K
25,000 sh × $30.00
Exec Oct 8 2025
Filed Oct 10 2025 · 5:30 PM ET STOKSALE Stoke Therapeutics, Inc. $1.1M
42,461 sh × $25.09
Exec Oct 3 2025
Filed Oct 7 2025 · 5:30 PM ET STOKSALE Stoke Therapeutics, Inc. $221K
12,126 sh × $18.24
Exec Aug 18 2025
Filed Aug 20 2025 · 5:30 PM ET